Champions Oncology was founded by some of the world’s most renowned specialists in the field of cancer diagnosis, treatment, and research. Our team is comprised of seasoned oncology professionals passionately dedicated to working with you to accelerate oncology drug development, improve outcomes and extend lives. Our core platform, the Champions TumorGraft™ offers an enhanced xenograft mouse avatar model for growing and testing human tumors.
-
Personalized Oncology Solutions
Personalized Champions TumorGrafts™ empower patients and physicians using an in vivo xenograft mouse avatar-based diagnostic model that has shown to be predictive of a patients' clinical response to cancer treatments and anticancer therapies.
-
Translational Oncology Solutions
Translational Oncology Solutions uses the innovative Champions TumorGraft™ platform to accelerate the development on oncology drugs by predicting their clinical effectiveness.
Champions TumorGrafts™:
- Correlate to actual patient outcomes
- Are more predictive than xenografts
- Provide early identification of anticancer agent efficacy
- Facilitate the identification of the right patient population for each oncology compound
- Allow for focused and higher probability translational path